Tabukum, BS: Writingoriginal draft preparation and writingreview and editing
Rarely do more significant adverse effects such as allergic reactions, gallbladder problems, or pancreatitis occur, but they can
Although they have not yet been approved for neurological indications, this application reflects the expanding therapeutic landscape of incretin-based agents beyond classical metabolic targets
BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity
Patients with active psychiatric conditions, epilepsy, or significant cardiovascular disease require careful evaluation before starting
You need to reach the maintenance dose (7.2mg) for the most effective results and it takes 20 weeks (or longer) to reach this dose